Bromfed DM: Clinical Information
Bromfed DM is a combination over-the-counter cough and cold medication containing brompheniramine (antihistamine), pseudoephedrine (decongestant), and dextromethorphan (cough suppressant) that has limited evidence supporting its use and carries significant contraindications and adverse effects that must be carefully considered before prescribing.
Indications
Bromfed DM is marketed for symptomatic relief of cough associated with upper respiratory infections. However, the evidence does not support routine use of combination OTC cough medications 1. The ACCP guidelines specifically state that over-the-counter combination cold medications (with the exception of older antihistamine-decongestant combinations) are not recommended until randomized controlled trials prove they are effective cough suppressants 1.
For the individual components:
- Dextromethorphan: May provide short-term symptomatic relief in chronic bronchitis (Grade B recommendation), but has limited efficacy in acute URI-related cough 1
- First-generation antihistamines (like brompheniramine): May be suitable for nocturnal cough due to sedative properties 2
- The combination formulation lacks specific evidence for superiority over individual agents
Contraindications (FDA Label)
Absolute contraindications 3:
- Hypersensitivity to any ingredient
- Newborns and premature infants
- Nursing mothers
- Severe hypertension
- Severe coronary artery disease
- Concurrent MAOI use (critical drug interaction with dextromethorphan)
- Lower respiratory tract conditions including asthma (antihistamines contraindicated)
Dosing Regimen
Standard manufacturer dosing for dextromethorphan component typically follows age-based recommendations, though this approach results in substantial variability in weight-adjusted dosing 4. The FDA has restricted prescription opioid cough medications to adults ≥18 years 5, and similar caution applies to dextromethorphan-containing products in children.
Important dosing considerations:
- Maximum cough reflex suppression with dextromethorphan occurs at 60 mg and can be prolonged 2
- Generally recommended dosages are likely subtherapeutic 2
- Care must be taken with combination products containing additional ingredients like acetaminophen 2
Common Adverse Effects
Most frequent adverse reactions 3:
- Sedation
- Dry mouth, nose, and throat
- Thickening of bronchial secretions
- Dizziness
Other significant adverse effects 3:
- Cardiovascular: Hypotension, hypertension, cardiac arrhythmias, palpitations
- CNS: Disturbed coordination, tremor, irritability, insomnia, visual disturbances, weakness, nervousness, convulsions, headache, euphoria, dysphoria
- Respiratory: Chest tightness, wheezing, shortness of breath
- Hematologic: Hemolytic anemia, thrombocytopenia, agranulocytosis (rare but serious)
- GI: Epigastric discomfort, anorexia, nausea, vomiting, diarrhea, constipation
- GU: Urinary frequency, difficult urination
- Dermatologic: Urticaria, drug rash, photosensitivity, pruritus
Critical Safety Concerns
Abuse potential: Dextromethorphan abuse is the most significant hazard identified in safety analyses 6. At supratherapeutic doses (>2 mg/kg), the drug produces dissociative effects similar to ketamine and phencyclidine 7. Massive ingestions may cause tachycardia, hypertension, and respiratory depression 7.
Drug interactions: The combination of dextromethorphan with MAOIs can cause serotonin syndrome 8. Patients taking SSRIs or MAOIs require careful monitoring for up to 8 hours after ingestion 8.
Pediatric considerations: OTC cough medications have little to no benefit in children and are associated with significant morbidity and mortality 5, 9. The FDA issued warnings against use in children under 4 years of age 5.
Clinical Recommendations
For acute viral cough: Simple home remedies like honey and lemon are preferred over OTC medications 2. Honey may offer more relief than diphenhydramine or placebo in children 5.
For chronic bronchitis: If antitussive therapy is warranted, single-agent dextromethorphan or codeine may provide short-term symptomatic relief 1, but combination products add unnecessary components without proven additional benefit.
Avoid in: Patients with lower respiratory tract disease, those on MAOIs or SSRIs, children under 4 years, pregnant/nursing women, and those with cardiovascular disease 3.
Monitor for: Signs of abuse (particularly in adolescents and young adults), anticholinergic effects, cardiovascular effects, and drug interactions 3, 7, 6.